Wray and Mayorkas Were Set to Testify Today. They Didn't Show Up.
Matt Gaetz Withdraws From Attorney General Nomination
Bucks County Dem Apologizes for Trying to Steal the PA Senate Race
Homan Says They'll 'Absolutely' Use Land Texas Offered for Deportation Operation
For the First Time in State History, California Voters Say No to Another...
Breaking: ICC Issues Arrest Warrants for Netanyahu, Gallant
Begich Flips Alaska's Lone House Seat for Republicans
It's Hard to Believe the US Needs Legislation This GOP Senator Just Introduced,...
FEMA Director Denies, Denies, Denies
The System Finally Worked for Laken Riley -- Long After Her Entirely Avoidable...
Gun Ownership Is Growing Among This Group of Americans
We’ve Got an Update on Jussie Smollett…and You’re Not Going to Like It
Here’s How Many FCC Complaints Were Filed After Kamala Harris’ 'SNL' Appearance
By the Numbers: Trump's Extraordinary Gains Among Latinos, From Texas to...California?
John Oliver Defended Transgender Athletes Competing in Women’s Sports. JK Rowling Responde...
Tipsheet

Rand Paul Corners Fauci on Quietly Changing Gain-of-Function Definition

AP Photo/J. Scott Applewhite, Pool

Dr. Anthony Fauci is back on Capitol Hill Thursday for questioning in front of the Senate Health Committee. 

Under questioning from Dr. Rand Paul, Fauci again attempted to redefine the meaning of gain-of-function research. 

Advertisement

Fauci has repeatedly denied his agency funded dangerous gain-of-function research at the Wuhan Institute of Virology. Recently, the National Institute of Health disputed that claim

"The fifth and final progress report for Grant R01AI110964, awarded to EcoHealth Alliance, Inc. is attached with redactions only for personally identifiable information," NIH Principal Deputy Director Larence Tabak explained in a letter to Republican Congressman James Comer. "It includes data from a research project conducted during the 2018-2019 grant period using bat coronavirus genome sequences already existing in nature."

Advertisement

"The limited experiment described the final progress report provided by EcoHealth Alliance was testing if spike proteins from naturally occurring bat coronaviruses circulating in China were capable of biding to the human ACE2 receptor in a mouse model," the letter continues. "In this limited experiment, laboratory mice infected with the SHC014 W1V1 bat coronavirus became sicker than those infected with the W1V1 bat coronavirus."

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement